WeVote
Log In

Bill

Bill

HD 2251

An Act relative to epinephrine injectors

194th Legislature (2025-2026) Introduced by Kim Ferguson and 4 co-sponsors

Massachusetts bill expands public access to epinephrine auto-injectors to reduce anaphylaxis deaths in schools and community settings.

0
WeVote Research Nonpartisan
Bill Summary · HD 2251

Legislative bill overview

HD 2251 aims to improve access to epinephrine auto-injectors (EpiPens) in Massachusetts, likely by addressing availability, cost, prescription requirements, or distribution in schools and public spaces. The bill is sponsored by a bipartisan group of state representatives, suggesting broad support for expanding epinephrine access as a public health measure.

Why is this important

Epinephrine auto-injectors are life-saving devices for individuals experiencing severe allergic reactions (anaphylaxis), which can be fatal within minutes. Expanding access—particularly in schools, workplaces, and public venues—can reduce mortality and emergency room visits, while addressing gaps in availability for uninsured or low-income individuals.

Potential points of contention

  • Liability concerns: Schools and public entities may worry about legal liability if they stock and administer epinephrine auto-injectors without direct medical oversight
  • Cost allocation: Disagreement over whether costs should fall on schools, municipalities, insurers, or the state budget
  • Prescription requirements: Balancing expanded access against medical licensing laws and the role of pharmacists versus physicians in authorizing epinephrine distribution

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.